From catheters to vectors: The dawn of molecular electrophysiology

Nature Medicine

Volumn 6, Issue 12, 2000, Pages 1316-1318

  Priori, S G ^a   Napolitano, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; MUSCARINIC M2 RECEPTOR;

AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; DEFIBRILLATOR; GENE THERAPY; GENE TRANSFER; GENETIC MANIPULATION; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART CONDUCTION; HEART RATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; SUPRAVENTRICULAR TACHYCARDIA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; GENE THERAPY; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; SWINE;

EID: 0034536071     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/82116     Document Type: Short Survey

References (10)

1. Focal modification of electrical conduction in the heart by viral gene transfer
2. The G-protein nanomachine
3. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction
4. Italian Sudden Death Prevention Group: Prevention of Sudden Death after first myocardial infarction by pharmacological or surgical antiadrenergic intervention
5. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification
6. Beta blockade in heart failure: Basic concepts and clinical results
7. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management part I and II
8. The M cell
9. I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium
10. Mortality and Morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmias Suppression Trial